By Therapeutic Area

Oncology. Breast Cancer Market Analysis

Cross-industry research covering Oncology. Breast Cancer across 1 market reportspanning Medical Devices & Surgical Navigation.

1 Reports

1 Industries

Reports Covering Oncology. Breast Cancer

Breast Lesion Localization Methods Market to Reach USD 1.42B by 2033 at 8.3% CAGR

Medical Devices & Surgical Navigation·Market: USD 0.74 Billion (2025)·CAGR: 8.3%

Breast cancer is the dominant indication, encompassing invasive ductal carcinoma, invasive lobular carcinoma, ductal carcinoma in situ (DCIS), and post-neoadjuvant residual disease localization. Cancer statistics 2025 (openalex:W4406431707) reinforce persistently high incidence volumes that mechanically sustain procedure demand. Neoadjuvant therapy response assessment, where a clip must localize the original tumor bed after chemotherapy-induced regression, represents the fastest-growing sub-use case within this segment.

78%

Market Share

8.6%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments